Abstract:Dermatology is undergoing a paradigm shift towards an understanding of the value of qualitative research, with the BJD in the vanguard. Autumn 2017 sees a first for the journal – a special section in our September edition that builds on our mission to support the development of high-quality qualitative research in dermatology. A BJD call for qualitative research showcasing methodological excellence was made in autumn 2016. Manuscripts providing significant insight into the perspectives or experiences of patients, carers or clinicians and clearly demonstrating added value to dermatology were welcomed. The call attracted a wide range of submissions. Over one-third did not make it to the initial review stage because the authors failed to comply with the journal’s standards for qualitative papers. The lower-quality submissions often shared a common factor: failure to include qualitative expertise in the authorship team (although having an expert on board was by no means a guarantee of success). Our qualitative reviewers are stringent and rightly so. We aim to publish only the best qualitative work in the BJD – and six papers (Table 1) have been selected for the special section. The studies offer insights into some of the intriguing ‘why?’ and ‘how?’ questions in our field. For example: why do patients delay help seeking for skin issues, what motivates people to talk about skin-related health risks, and how might a skin-focused intervention work to promote behaviour change? The studies are methodologically diverse, spanning the research continuum from literature synthesis to intervention testing and evaluation. In some cases ‘mixed methods’ are used in which statistics provide breadth, and detailed qualitative methods provide depth. The studies hail from a range of theoretical perspectives and, importantly, comprise interdisciplinary authorship teams that see dermatology colleagues working jointly with experts from applied health services, nursing, public health, primary care, psychology, medical education, philosophy, epidemiology, medical sociology, bioethics and health economics. These studies are testament to the value of researchers operating across methodological and professional boundaries, demonstrating that interdisciplinary working can produce excellent qualitative skin-focused research. This body of work also challenges inaccurate stereotypes regarding qualitative research, such as the belief that it lacks rigour or cannot produce implications for practice. Bath-Hextall and colleagues’ metasynthesis of the needs and experiences of patients with both keratinocyte carcinoma and melanoma is an excellent example of a qualitative systematic review, an approach that is supported by the Cochrane Collaboration. This method, which can be compared with the quantitative meta-analysis approach, enables summarization and synthesis of existing qualitative research findings to generate new knowledge with enhanced transferability. Fourteen studies were subjected to rigorous appraisal prior to synthesis of the findings using a pragmatic meta-aggregative approach to establish that both patient groups experience many similar psychosocial issues, which can guide practice and future research. In-depth semistructured interviews with framework analysis were used by Simpson and colleagues to examine the reasons why people with psoriasis often delay seeking help. Using this systematic but flexible five-step analytical method the researchers were able to identify a range of negative patient beliefs that were associated with delay in presentation. Notably, these factors are modifiable if targeted early enough so that people with psoriasis can be enabled to obtain timely, effective treatment and achieve their full life potential. Framework analysis is particularly suited to applied health research, where researchers have specific, pre-existing questions, a limited time frame and an interdisciplinary study team. Qualitative analysis of the content of online forums is a novel means of gaining access to people’s expressed experience, perspectives and peer interactions in a ‘naturalistic’ setting. The study of Santer et al. on people with acne seeking advice for oral antibiotics applies this methodology to skin disease. Acne is a singularly appropriate topic for this approach: it is a common, recurring condition especially prevalent in a younger demographic who will have higher levels of familiarity and comfort with an online forum context. Using a thematic analysis approach the authors were able to highlight the diversity of views among affected people and the potential for misinformation and misunderstanding to arise from online interactions.

Restoring MLL reactivates latent tumor suppression-mediated vulnerability to proteasome inhibitors

Targeting HDAC9 Contributes to Degradation of MLL Fusion Oncoproteins in KMT2A-Rearranged Acute Myeloid Leukemia

A Distinct Epigenetic Signature at Targets of a Leukemia Protein

Unraveling MLL1-fusion Leukemia: Epigenetic Revelations from an iPS Cell Point Mutation

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia

Novel therapeutic strategies for MLL-rearranged leukemias

Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins

Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity

Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia in Vivo.

Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

Involvement of PML-I in Reformation of PML Nuclear Bodies in Acute Promyelocytic Leukemia Cells by Leptomycin B

Six of the best: how excellent qualitative research can contribute to practice

A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia

PML Mutation in PML-Rarα Alters PML Nuclear Body Organization and Induces ATRA Resistance in Acute Promyelocytic Leukemia

Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells

A field study of the microbiological quality of fresh produce.

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

MLLT6/ATF2 axis restrains breast cancer progression by driving DDIT3/4 expression

Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity

Abstract 3330: BPP, a dual functional inhibitor, targets MLL-rearranged acute myeloid leukemia: Unraveling mechanisms and expanding therapeutic horizons